tiprankstipranks
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market
JANX
Janux Therapeutics Inc
RESEARCH TOOLSreports
Want to see JANX full AI Analyst Report?

Janux Therapeutics Inc (JANX) Income Statement

716 Followers

Janux Therapeutics Inc Income Statement

Last quarter (Q4 2025), Janux Therapeutics Inc's total revenue was $7.88M, an increase of Infinity% from the same quarter last year. In Q4, Janux Therapeutics Inc's net income was $-31.95M. See Janux Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 10.00M$ 10.59M$ 8.08M$ 8.61M$ 3.64M
Gross Profit
$ 7.97M$ 8.53M$ 6.13M$ 7.77M$ 3.64M
Operating Expenses
$ 165.64M$ 107.38M$ 79.11M$ 74.86M$ 36.57M
Depreciation and Amortization
$ 2.03M$ 2.06M$ 1.96M$ 841.00K$ 113.00K
EBITDA
$ -111.60M$ -96.79M$ -71.02M$ -66.25M$ -32.82M
Operating Income
$ -157.67M$ -98.85M$ -72.98M$ -67.09M$ -32.93M
Other Income/Expenses
$ 44.04M$ 29.85M$ 14.69M$ 4.03M$ 257.00K
Pretax Income
$ -113.63M$ -68.99M$ -58.29M$ -63.06M$ -32.67M
Net Income
$ -113.63M$ -68.99M$ -58.29M$ -63.06M$ -32.67M
Per Share Metrics
Basic EPS
$ -1.83$ -1.28$ -1.32$ -1.52$ -0.79
Diluted EPS
$ -1.83$ -1.28$ -1.32$ -1.52$ -0.79
Weighted Average Shares Outstanding
 61.97M 53.75M 44.02M 41.47M 41.24M
Weighted Average Shares Outstanding (Diluted)
 61.97M 53.75M 44.02M 41.47M 41.24M
Currency in USD

Janux Therapeutics Inc Earnings and Revenue History